Annah S Rolig

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 9

Top Venues

Cancer immunology research

Oncoimmunology

Molecular cancer research : MCR

Bioanalysis

Providence Cancer Center

University of California Santa Cruz (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Providence Cancer Center Jul 17 2017

United States

Research Scientist :: Earle E. Chiles Cancer Research Institute

University of Oregon

United States

Post-doctoral Fellow :: Biology - Institute of Molecular Biology

Education History

University of California Santa Cruz

United States

PHD :: Molecular, Cell, and Developmental Biology

Colorado State University

United States

BSC :: Biology

Publications

Daniel C Rose, Annah S Rolig, William L Redmond
Characterization of murine lymphocyte activation and exhaustion markers by a 14-color flow cytometry panel. Bioanalysis (2023)
Mia Han, Bianca Nguyen, Jack Y Lee, Erica Browning, Jun Zhang, Anandaroop Mukhopadhyay, Ravindra Gujar, Jon Salazar, Reneta Hermiz, Lauren Svenson, Annah S Rolig, William L Redmond, Alain Patrick Algazi, Adil I Daud, David A Canton, Christopher G Twitty
Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity. Molecular cancer research : MCR 20 (6) (2022)
Annah S Rolig, Daniel C Rose, Grace Helen McGee, Werner Rubas, Saul Kivimäe, William L Redmond
Combining bempegaldesleukin (CD122-preferential IL-2 pathway agonist) and NKTR-262 (TLR7/8 agonist) improves systemic antitumor CD8 + T cell cytotoxicity over BEMPEG+RT. Journal for immunotherapy of cancer 10 (4) (2022)
Elizabeth R Sturgill, Annah S Rolig, Stefanie N Linch, Courtney Mick, Melissa J Kasiewicz, Zhaoyu Sun, Peter G Traber, Harold Shlevin, William L Redmond
Galectin-3 inhibition with belapectin combined with anti-OX40 therapy reprograms the tumor microenvironment to favor anti-tumor immunity. Oncoimmunology 10 (1) (2021)
Dana A Emerson, Annah S Rolig, William L Redmond
Enhancing the Generation of Eomeshi CD8+ T Cells Augments the Efficacy of OX40- and CTLA-4-Targeted Immunotherapy. Cancer immunology research 9 (4) (2021)
Mark D Badeaux, Annah S Rolig, Giulia Agnello, Danlee Enzler, Melissa J Kasiewicz, Leslie Priddy, Jason F Wiggins, Alexander Muir, Mark R Sullivan, Jessica Van Cleef, Christopher Daige, Matthew G Vander Heiden, Venkatesh Rajamanickam, James E Wooldridge, William L Redmond, Scott W Rowlinson
Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth. Cancer immunology research 9 (4) (2021)
Mohammad Farhad Amani, Annah S Rolig, William L Redmond
Intracellular Galectin-3 Is Essential for OX40-Mediated Memory CD8+ T Cell Development. Journal of immunology (Baltimore, Md. : 1950) 205 (7) (2020)
Annah S Rolig, Emily Goers Sweeney, Lila E Kaye, Michael D DeSantis, Arden Perkins, Allison V Banse, M Kristina Hamilton, Karen Guillemin
A bacterial immunomodulatory protein with lipocalin-like domains facilitates host-bacteria mutualism in larval zebrafish. eLife 7 (2018)
Annah S Rolig, Erika K Mittge, Julia Ganz, Josh V Troll, Ellie Melancon, Travis J Wiles, Kristin Alligood, W Zac Stephens, Judith S Eisen, Karen Guillemin
The enteric nervous system promotes intestinal health by constraining microbiota composition. PLoS biology 15 (2) (2017)

Annah S Rolig.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Annah S Rolig